- Individualized pharmacotherapy of plaque psoriasis with oral methotrexate: fiction or real possibility?2012 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis +12008 | Faculty of Medicine in Hradec Králové
- The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis2008 | First Faculty of Medicine
- A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment +12008 | Faculty of Medicine in Hradec Králové
- Modelling of low-dose oral methotrexate (MTX) pharmacokinetics (PK) and pharmacodynamics (PD) in the therapy of severe psoriasis (PS)Publication without faculty affiliation
- A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment2008 | First Faculty of Medicine
- Folate and homocysteine status in patients with psoriasis treated with low dose oral methotrexate (MTX), and the effect of folic acid (FA) supplementPublication without faculty affiliation
- 677TT Genotype Is Associated with Elevated Risk of Methotrexate (MTX) Toxicity in Juvenile Idiopathic Arthritis: Treatment Outcome, Erythrocyte Concentrations of MTX and Folates, and MTHFR Polymorphisms2010 | First Faculty of Medicine
- Effect of tocilizumab in a patient with corticosteroid-resistant temporal arteritis2018 | First Faculty of Medicine
- Relationship between pharmacokinetics and therapeutic and adverse effects of methotrexate during the initial phase of treatment of moderate-severe and severe psoriasis2006 | Faculty of Medicine in Hradec Králové
- Relationship between pharmacokinetics and therapeutic and adverse effects of methotrexate during the initial phase of treatment of moderate-severe and severe psoriasis2006 | First Faculty of Medicine
- Brentuximab vedotin in the treatment of relapsed CD30 positive cutaneous lymphoma - results of an international, open label, randomised, phase 3, multicentre trial - ALCANZA2018 | Faculty of Medicine in Hradec Králové
- Assessment of methotrexate hepatotoxicity in psoriasis patients: a prospective evaluation of four serum fibrosis markers2013 | Faculty of Medicine in Hradec Králové